Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q4 2025 Earnings Conference Call. [Operator ...

Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...

A conversation with Newton-based inventor, author, and computer scientist, who believes technology will help humans extend ...

Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its ...

Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings results soon.

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and carcass quality.

In this interview, law professor Corinna Barrett Lain discusses her book 'Secrets of the Killing State,' which exposes the ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...